Business model
For our customers and partners we custom engineer ”InGell” injectable hydrogel systems towards the optimal release profile of the active pharmaceutical ingredient in play.
Our business model is a combination of dedicated development agreements, licensing agreements and supply agreements.
Collaborations are always custom-made but generally follow the path of:
1. Feasilibility studies;
2. Basic agreement on licensing conditions;
3. Full development program;
4. Full agreement on licensing conditions;
5. Supply chain securement.